A Japanese patient paralyzed for years can now stand unaided after participating in a groundbreaking clinical trial using reprogrammed stem cells. Conducted by Hideyuki Okano at Keio University, the trial suggests potential for regenerative medicine. While the treatment was deemed safe, experts call for larger trials to confirm its effectiveness in treating spinal injuries.